Yasuhiro Takeuchi

8PUBLICATIONS
31CO-AUTHORS
Molecular targetsPharmacogenomicsBiomechanicsEpidemiological methodsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 10, 2025
Authors' response to 01460, renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings.

Yasuhiro Takeuchi, Shiro Tanaka, Tatsuhiko Kuroda

|Mar 09, 2025
Romosozumab and cardiovascular safety in Japan.

Yasuhiro Takeuchi

|Jan 17, 2025
Cardiovascular safety of osteoanabolic agents.

Yasuhiro Takeuchi

|Sep 29, 2024
Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05.

Yasuhiro Takeuchi, Shiro Tanaka, Tatsuhiko Kuroda

|Aug 14, 2024
Predictors of discontinuation of osteoporosis treatment: sub-analysis of the Japanese osteoporosis intervention trial-05 (JOINT-05).

Yasuhiro Takeuchi, Yuki Nakatsuka, Shiro Tanaka

Pageof 2